Study Comparing One Versus Two Cortisone Injections for Trigger Finger
NCT00951236 is an interventional trial sponsored by Rothman Institute Orthopaedics. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies One cortisone injection and Two cortisone Injections in Stenosing Tenosynovitis and Trigger Finger. The registry lists an enrollment of 392 participants at 7 sites in 1 country. The registry lists a start date of 31 May 2009.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00951236 |
| Status | Unknown |
| Study type | Interventional trial |
| Lead sponsor | Rothman Institute Orthopaedics |
| Enrollment | 392 |
| Registered sites | 7 |
| Countries | 1 |
| Conditions | Stenosing Tenosynovitis and Trigger Finger |
| Drugs | One cortisone injection and Two cortisone Injections |
| Start | 31 May 2009 |
| Last update posted | 12 Feb 2014 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Charles Leinberry, MD
Rothman Institute
Principal Investigator - Emran Sheikh, MD
Rothman Institute
Principal Investigator - Pedro Beredjiklian, MD
Rothman Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rothman Institute: Egg Harbor Township Location
Egg Harbor
Emran Sheikh, MDRecruiting - Rothman Institute: Manahawkin Location
Manahawkin
Emran Sheikh, MDRecruiting - Rothman Institute: Vorhees Location
Vorhees
Pedro Berendjiklian, MDRecruiting
- Rothman Institute: Media Location
Media
Pedro Berendjiklian, MDRecruiting - Rothman Institute Center City Location
Philadelphia
Charles Leinberry, MDEmran Sheikh, MDPedro Beredjiklian, MDRecruiting - Rothman Institute, Northeast Philadelphia Location
Philadelphia
Charles Leinberry, MDRecruiting - Rothman Institute, South Philadelphia Location
Philadelphia
Charles Leinberry, MDRecruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Questions about NCT00951236
Each answer restates registry values shown on this page.
What is NCT00951236?
NCT00951236 is an interventional trial sponsored by Rothman Institute Orthopaedics. It studies One cortisone injection and Two cortisone Injections in Stenosing Tenosynovitis and Trigger Finger.
Who leads NCT00951236?
The registry names Charles Leinberry, MD (principal investigator, Rothman Institute), Emran Sheikh, MD (principal investigator, Rothman Institute) and Pedro Beredjiklian, MD (principal investigator, Rothman Institute) as overall officials.
Where does NCT00951236 run?
The registry lists 7 sites in 1 country. Every site with a stated country is in one country: United States.
Which drugs does NCT00951236 study?
The registered drug and biological interventions are One cortisone injection and Two cortisone Injections.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.